Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorRoswell Park Cancer Institute

About this trial

This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age ≥ 21 years of age

Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming)

Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year

Open to trying a non-combusted oral tobacco product

Disqualifiers

Age ≥ 21 years of age

Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming)

Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year

Open to trying a non-combusted oral tobacco product

Trial design

Design model

Factorial

Treatments tested in this trial

  • Copenhagen group

    Other intervention

    Participants use product for up to 30 minutes

  • Snus group

    Other intervention

    Participants use product for up to 30 minutes

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Copenhagen groupActive comparator 1 intervention
Group B: Snus GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in sensory response

assessed with a 0-100 visual analog scale - anchored by word descriptors at each end.

Time frame
Before viewing study ads and immediatley after viewing

Secondary outcomes

1

Change in nicotine boost

Will be measured after use of products with gas chromatography-mass spectrometry

Time frame
Will be collected after 5, 15 and 30 minutes of product use.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Roswell Park Cancer Institute

Lead sponsor

National Cancer Institute (NCI)

Collaborator